Enzymatica AB (publ) (FRA:EN9)

Enzymatica AB Statistics

Total Valuation

Enzymatica AB has a market cap or net worth of EUR 44.21 million. The enterprise value is 41.21 million.

Market Cap	44.21M
Enterprise Value	41.21M

Important Dates

The last earnings date was Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	242.74M
Shares Outstanding	n/a
Shares Change (YoY)	+25.94%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	7.01%
Owned by Institutions (%)	14.39%
Float	106.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.88
PB Ratio	3.85
P/TBV Ratio	7.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.59
EV / Sales	8.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.82

Financial Position

The company has a current ratio of 3.65, with a Debt / Equity ratio of 0.01.

Current Ratio	3.65
Quick Ratio	2.59
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	-41.73

Financial Efficiency

Return on equity (ROE) is -34.53% and return on invested capital (ROIC) is -21.14%.

Return on Equity (ROE)	-34.53%
Return on Assets (ROA)	-19.04%
Return on Invested Capital (ROIC)	-21.14%
Return on Capital Employed (ROCE)	-41.37%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	249,040
Profits Per Employee	-239,739
Employee Count	21
Asset Turnover	0.32
Inventory Turnover	1.17

Taxes

In the past 12 months, Enzymatica AB has paid 4,713 in taxes.

Income Tax	4,713
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +29.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+29.22%
50-Day Moving Average	0.15
200-Day Moving Average	0.18
Relative Strength Index (RSI)	55.85
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Enzymatica AB had revenue of EUR 4.98 million and -4.79 million in losses. Loss per share was -0.02.

Revenue	4.98M
Gross Profit	3.06M
Operating Income	-4.75M
Pretax Income	-4.79M
Net Income	-4.79M
EBITDA	-4.49M
EBIT	-4.75M
Loss Per Share	-0.02

Balance Sheet

The company has 3.06 million in cash and 94,528 in debt, with a net cash position of 2.97 million.

Cash & Cash Equivalents	3.06M
Total Debt	94,528
Net Cash	2.97M
Net Cash Per Share	n/a
Equity (Book Value)	11.47M
Book Value Per Share	0.05
Working Capital	4.36M

Cash Flow

In the last 12 months, operating cash flow was -3.79 million and capital expenditures -21,345, giving a free cash flow of -3.81 million.

Operating Cash Flow	-3.79M
Capital Expenditures	-21,345
Free Cash Flow	-3.81M
FCF Per Share	n/a

Margins

Gross margin is 61.45%, with operating and profit margins of -95.30% and -96.27%.

Gross Margin	61.45%
Operating Margin	-95.30%
Pretax Margin	-96.17%
Profit Margin	-96.27%
EBITDA Margin	-90.05%
EBIT Margin	-95.30%
FCF Margin	n/a

Dividends & Yields

Enzymatica AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.94%
Shareholder Yield	-25.94%
Earnings Yield	-10.84%
FCF Yield	-8.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2